Search Results - mohammed+masmudur+rahman

2 Results Sort By:
Enhanced Combinatorial Oncolytic Virotherapy
Oncolytic viruses (OVs) are able to selectively infect and kill cancer cells without damaging normal cells. They can be used as a monotherapy, or they can be combined with existing cancer therapeutics for increased potency. While much progress has been made around OVs, one of their biggest limitations is their inability to successfully replicate, spread,...
Published: 2/26/2026   |   Updated: 3/31/2025   |   Inventor(s): Mohammed Masmudur Rahman
Keywords(s):  
Category(s): Cancer, Cancer Therapeutics, Life Science (All LS Techs), Pharmaceuticals
High Efficacy Vaccine and Microbicide Combination For Use Against HIV
Summary: NCI is seeking research co-development partners and/or licensees to evaluate, further develop or commercialize this high efficacy vaccine and microbicide combination for use against HIV. Description of Technology: Human immunodeficiency virus (HIV) remains a major global health challenge despite the advancement made in development of effective...
Published: 4/23/2026   |   Updated: 8/2/2023   |   Inventor(s): Genoveffa Franchini, Marjorie Robert-Guroff, Daniel Appella, Sabrina Helmold Hait, Mohammed Rahman, Massimiliano Bissa, Ettore Appella, Lisa Marie Jenkins, Isabela Silva De Castro
Keywords(s): Acquired Immuno-Deficiency Syndrome, ADCC, AIDS, Antibody-dependent Cellular Cytotoxicity, Efferocytosis, Envelope Glycoprotein 120, Envelope Variable Region, Franchini, gp120, HIV, Human Immunodeficiency Virus, Microbicide, SAMT-247, V1, Vaccine
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Infectious Disease, TherapeuticArea > Immunology, Application > Vaccines